about
Extreme Procalcitonin Elevation without Proven Bacterial Infection Related to Amphetamine AbuseRapamycin reverses paraquat-induced acute lung injury in a rat model through inhibition of NFκB activationC-reactive protein is differentially modulated by co-existing infections, vitamin deficiencies and maternal factors in pregnant and lactating indigenous Panamanian women.Multi-parameter determination of TNFα, PCT and CRP for point-of-care testing.Coincident helminth infection modulates systemic inflammation and immune activation in active pulmonary tuberculosis.Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.Accuracy and feasibility of point-of-care white blood cell count and C-reactive protein measurements at the pediatric emergency department.Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC).Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection.Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections.Use of laboratory tests in out-of-hours services in Norway.Influence of in-line microfilters on systemic inflammation in adult critically ill patients: a prospective, randomized, controlled open-label trialWash-free, electrochemical platform for the quantitative, multiplexed detection of specific antibodiesCirculating biomarkers of pulmonary and extrapulmonary tuberculosis in children.Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection.The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients.Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal functionA point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10Strategies for reduction in duration of antibiotic use in hospitalized patients.Molecular analysis of blood with micro-/nanoscale field-effect-transistor biosensors.Procalcitonin as a biomarker of infectious diseases.Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation, and thrombogenesis.Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient.Evaluation of the Microsemi CRP, an automated hematology analyzer for rapid 3-part WBC differential and CRP using whole blood.Association between increased blood interleukin-6 levels on emergency department arrival and prolonged length of intensive care unit stay for blunt traumaInterpretation of C-reactive protein concentrations in critically ill patients.Basic evaluation of Pentra MS CRP, a new automated hematology analyzer for rapid 5-part WBC differential and CRP using a small volume of whole blood.Five days of head-down-tilt bed rest induces noninflammatory shedding of L-selectin.Vertical flow immunoassay (VFA) biosensor for a rapid one-step immunoassay.Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection.Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease.DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin.Correlation of ischemia-modified albumin with SOFA and APACHE II scores in preoperative patients with colorectal cancer.
P2860
Q21284729-596B61DB-99AA-4248-8120-1150ACC0B1BCQ28383433-F3104BAA-251A-42B3-AD76-F17FA36F9E17Q33755777-8A81BECE-0612-4CC5-A464-F40052CD71FCQ33771781-A38F3A4B-1F7C-45A0-8156-24D12733E09CQ34465369-605A7905-57EC-4252-B8CE-781BA5356163Q35152646-33E96E8B-7E29-46EB-A2F7-E7BA0A5730AAQ35649633-B6AE7C41-0235-443D-8DEB-1EC3F747F815Q35678916-05D8F4A3-5166-4391-9539-529598FEE598Q35739062-839EEE80-1521-4008-814E-BDB7D56111D0Q35998747-F267D0F4-3703-4634-B120-57F25D704602Q36041592-7D424315-D112-4560-86DE-C13DB942C197Q36249366-FC198A73-EB7D-492B-90C4-8F8C20A0EFD5Q36470897-A1B81C42-DA1B-43B6-999C-9EC3FB65477CQ36826386-ABE55358-9EE8-485E-AEE1-186357D76CBAQ37124780-9FC7E43F-BD70-46E8-8251-D2D62B4DDFAFQ37154427-60092453-B468-4570-A338-2538F3412621Q37274188-BBF45C9E-AF19-4DC8-96A8-5495620D48B5Q37623851-8228D03C-6A00-4F1B-9DAF-E77E5739E5AAQ37867329-B3DA8C44-8055-4476-B128-C699A9A11DDCQ37884527-3EE15EAA-2CBE-4BB8-A088-DFA4A1C23267Q38107483-03C51D86-9096-4F13-9653-83D2C623A0FAQ38849046-C89B4BF2-7BD7-4C84-8274-52877C79F4DFQ40112217-A7EC116A-BAAA-4FBF-B8BC-8F11899A3360Q40124067-AADCCDC4-4EA1-4AEE-8FF9-BFF90F13084EQ40334857-A690D6FA-10FA-43E2-B9F4-6B7718C5C3FBQ40374354-D82D5E46-F9FF-4B82-AF58-991041D3E2CAQ40714413-7039A599-4D8E-4F98-8624-C0AD57FD4DC6Q41692073-2E074218-7EE4-494F-8F93-3FC050589B22Q41703823-C44025CE-E6C2-4D47-B52B-6287FCED4222Q41814037-3FDCB955-FFC0-45E9-BC22-9E7A1A2F682AQ42909180-C8E92595-FFE4-45A2-BE76-3161FB59D74FQ44280145-A270A9CE-30F5-4BB0-9693-1A5412F26E81Q45902927-98CD65AF-C870-4D08-8416-0E5BE3FC8328Q46713607-676BADD1-0D84-47F5-9C9A-43B15C70A720Q47102780-3DE422DB-1177-4BF0-AF3B-DA2E876A14CDQ48135665-D083C37B-FBC9-45EB-846B-5428F9A706F1Q52655059-E451C9E9-E6DB-4F7B-9DF5-80C4F73468D8Q55416725-7921939B-3AFE-484F-8E87-69870BB2A63F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation markers in point-of-care testing (POCT).
@en
Inflammation markers in point-of-care testing
@nl
type
label
Inflammation markers in point-of-care testing (POCT).
@en
Inflammation markers in point-of-care testing
@nl
prefLabel
Inflammation markers in point-of-care testing (POCT).
@en
Inflammation markers in point-of-care testing
@nl
P1476
Inflammation markers in point-of-care testing (POCT).
@en
P2093
Albrecht Pfäfflin
Erwin Schleicher
P2860
P2888
P304
P356
10.1007/S00216-008-2561-3
P407
P577
2008-12-23T00:00:00Z